Life Healthcare Group Holdings (JSE:LHC) Forward PE Ratio: 8.52 (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JSE:LHC Life Healthcare Group Holdings Ltd JSE:LHC
57 GF Score
Price R11.05
GF Value R15.64
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Life Healthcare Group Holdings Forward PE Ratio?

Life Healthcare Group Holdings JSE:LHC +2.31% 57 Forward PE Ratio is 8.52 as of Jul. 29, 2026. GuruFocus rates JSE:LHC with a GF Score™ of 57/100 and a GF Value™ of R15.64 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 314 Healthcare Providers & Services companies, Life Healthcare Group Holdings ranks better than 87.9% on this metric.

Life Healthcare Group Holdings's Forward PE Ratio for today is 8.52.

Life Healthcare Group Holdings's PE Ratio without NRI for today is 10.14.

Life Healthcare Group Holdings's PE Ratio (TTM) for today is 2.34.


Life Healthcare Group Holdings  (JSE:LHC) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Life Healthcare Group Holdings Forward PE Ratio Related Terms


Life Healthcare Group Holdings Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Life Healthcare Group Holdings's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Life Healthcare Group Holdings Forward PE Ratio Chart

Life Healthcare Group Holdings Annual Data
Trend 2016-09 2018-09 2019-09 2025-09
Forward PE Ratio
17.89 17.79 16.31 8.84

Life Healthcare Group Holdings Semi-Annual Data
2016-03 2016-09 2017-03 2018-03 2018-09 2019-03 2019-09 2020-03 2025-03 2025-09 2026-03
Forward PE Ratio 17.12 17.89 14.71 24.57 17.79 19.46 16.31 15.55 11.28 8.84 8.96

JSE:LHC vs HCA, THC, DVA: Forward PE Ratio Comparison

For the Medical Care Facilities subindustry, Life Healthcare Group Holdings's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Life Healthcare Group Holdings Forward PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Life Healthcare Group Holdings's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Life Healthcare Group Holdings's Forward PE Ratio falls into.


JSE:LHC
57GF Score
Life Healthcare Group Holdings Ltd JSE:LHC
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Life Healthcare Group Holdings Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 8.52 mean?
Life Healthcare Group Holdings (JSE:LHC) has a Forward PE Ratio of 8.52 as of Jul. 29, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Life Healthcare Group Holdings and its competitors. According to the industry distribution chart, Life Healthcare Group Holdings ranks #38 out of 314 companies in the Healthcare Providers & Services industry, placing it in the top 12.1%.
Is Life Healthcare Group Holdings' Forward PE Ratio too high?
Life Healthcare Group Holdings' current Forward PE Ratio is 8.52. The Healthcare Providers & Services industry median Forward PE Ratio is 18.33. Life Healthcare Group Holdings' value of 8.52 is 53.5% below this industry median. Based on the distribution chart, Life Healthcare Group Holdings ranks #38 out of 314 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Life Healthcare Group Holdings has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Life Healthcare Group Holdings' Forward PE Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Life Healthcare Group Holdings ranks #38 out of 314 companies for Forward PE Ratio. This places Life Healthcare Group Holdings in the top 12% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 18.33. Life Healthcare Group Holdings' value of 8.52 is 53.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.33, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Life Healthcare Group Holdings's current Forward PE Ratio of 8.52 is 53.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Life Healthcare Group Holdings and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Life Healthcare Group Holdings's current Forward PE Ratio is 8.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Life Healthcare Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Life Healthcare Group Holdings (JSE:LHC) is currently considered Modestly Undervalued. The stock's GF Value™ is R15.64, compared to a current price of R11.05 — trading 29.3% below its estimated fair value. The current Forward PE Ratio is 8.52 and 53.5% below the Healthcare Providers & Services industry median of 18.33. Life Healthcare Group Holdings' overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Life Healthcare Group Holdings (JSE:LHC), the current Forward PE Ratio is 8.52 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Life Healthcare Group Holdings (JSE:LHC) Overvalued in 2026?

Based on GuruFocus' analysis, Life Healthcare Group Holdings stock appears to be undervalued. The current stock price of R11.05 is trading 29.3% below its estimated GF Value™ of R15.64. GuruFocus considers Life Healthcare Group Holdings to be Modestly Undervalued.

Key valuation signals for JSE:LHC:

  • Forward PE Ratio: 8.52
  • GF Value™: R15.64 vs. price of R11.05 (29.3% below fair value)
  • GF Score™: 57/100 with 3 warning signs
  • Industry Position: 53.5% below the Healthcare Providers & Services median (#38 of 314)

No single metric tells the full story. See the JSE:LHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Life Healthcare Group Holdings Business Description

Address 203 Oxford Road, Oxford Parks, Corner Eastwood and Oxford Roads, Dunkeld, Johannesburg, GT, ZAF, 2196
Life Healthcare Group Holdings Ltd is a private healthcare provider in southern Africa, prominently serving the medically insured market. The company is in the business of providing hospital and complementary services (which include mental healthcare, acute rehabilitation, renal dialysis, oncology and diagnostics) and healthcare services. It operates via three segments: Hospitals segment (acute hospitals), the Complementary Services segment (mental health, acute rehabilitation, renal dialysis, oncology and diagnostics) and the Healthcare Services segment (Life Nkanyisa and Life Health Solutions). The majority of revenue is derived from the hospitals segment. Geographically, the company generates the maximum revenue from Southern Africa.
57GF Score

Get the complete analysis for JSE:LHC

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R11.05
Price
R15.64
GF Value